Hemenway Trust Co LLC boosted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 6.7% during the second quarter, Holdings Channel reports. The firm owned 14,669 shares of the pharmacy operator’s stock after buying an additional 915 shares during the period. Hemenway Trust Co LLC’s holdings in Walgreens Boots Alliance were worth $1,149,000 as of its most recent SEC filing.

Other hedge funds have also recently modified their holdings of the company. Howe & Rusling Inc. boosted its stake in shares of Walgreens Boots Alliance by 209.2% in the first quarter. Howe & Rusling Inc. now owns 1,441 shares of the pharmacy operator’s stock worth $120,000 after buying an additional 975 shares during the period. Regent Investment Management LLC boosted its stake in shares of Walgreens Boots Alliance by 8.5% in the first quarter. Regent Investment Management LLC now owns 80,129 shares of the pharmacy operator’s stock worth $6,655,000 after buying an additional 6,308 shares during the period. Pinnacle Bank purchased a new stake in shares of Walgreens Boots Alliance during the first quarter worth approximately $256,000. Oliver Luxxe Assets LLC boosted its stake in shares of Walgreens Boots Alliance by 8.2% in the first quarter. Oliver Luxxe Assets LLC now owns 9,064 shares of the pharmacy operator’s stock worth $753,000 after buying an additional 690 shares during the period. Finally, Tompkins Financial Corp boosted its stake in shares of Walgreens Boots Alliance by 5.1% in the first quarter. Tompkins Financial Corp now owns 41,578 shares of the pharmacy operator’s stock worth $3,503,000 after buying an additional 2,007 shares during the period. 61.16% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded up 0.85% during midday trading on Monday, hitting $81.41. 1,440,328 shares of the company were exchanged. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $88.00. The stock has a 50 day moving average of $79.08 and a 200 day moving average of $82.30. The firm has a market capitalization of $87.12 billion, a PE ratio of 20.56 and a beta of 1.25.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 EPS for the quarter, topping the consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The business had revenue of $30.12 billion for the quarter, compared to analyst estimates of $29.72 billion. During the same quarter in the previous year, the firm posted $1.18 earnings per share. Walgreens Boots Alliance’s quarterly revenue was up 2.1% on a year-over-year basis. On average, equities analysts predict that Walgreens Boots Alliance, Inc. will post $5.01 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Investors of record on Friday, August 18th will be paid a dividend of $0.40 per share. The ex-dividend date is Wednesday, August 16th. This represents a $1.60 annualized dividend and a yield of 1.96%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s payout ratio is presently 37.78%.

Walgreens Boots Alliance declared that its Board of Directors has initiated a stock repurchase program on Thursday, June 29th that permits the company to repurchase $5.00 billion in shares. This repurchase authorization permits the pharmacy operator to purchase up to 5.9% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

COPYRIGHT VIOLATION WARNING: “Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Bought by Hemenway Trust Co LLC” was posted by Watch List News and is owned by of Watch List News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.watchlistnews.com/walgreens-boots-alliance-inc-nasdaqwba-shares-bought-by-hemenway-trust-co-llc/1487332.html.

A number of brokerages have commented on WBA. Zacks Investment Research cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research report on Wednesday, June 14th. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 3rd. Jefferies Group LLC cut their price objective on shares of Walgreens Boots Alliance from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Wednesday, May 31st. Needham & Company LLC set a $94.00 price objective on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Monday, July 17th. Finally, Guggenheim reissued a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 3rd. Two investment analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $90.69.

In related news, Director William C. Foote sold 2,736 shares of the business’s stock in a transaction dated Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.